Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - The Lancet, 2016 - thelancet.com
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - The Lancet, 2016 - infona.pl
Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up,
and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier… - Lancet (London …, 2015 - europepmc.org
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - The Lancet, 2016 - Elsevier
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

[PDF][PDF] Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION) …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - Lancet, 2016 - academia.edu
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - Lancet, 2016 - boris.unibe.ch
BACKGROUND Data for the safety and efficacy of new-generation drug-eluting stents at
long-term follow-up, and specifically in patients with ST-segment elevation myocardial …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez… - Lancet (London …, 2016 - sonar.ch
METHODS In the multicentre EXAMINATION trial, done in Italy, Spain, and the Netherlands,
patients with ST-segment elevation myocardial infarction were randomly assigned in a 1: 1 …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra… - THE LANCET, 2016 - sfera.unife.it
Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year …

M Sabaté, S Brugaletta, A Cequier, A Iñiguez… - Lancet (London …, 2016 - folia.unifr.ch
METHODS In the multicentre EXAMINATION trial, done in Italy, Spain, and the Netherlands,
patients with ST-segment elevation myocardial infarction were randomly assigned in a 1: 1 …